Conditioning Brain Responses to Improve Thigh Muscle Function After Anterior Cruciate Ligament Reconstruction

NCT ID: NCT03209531

Last Updated: 2025-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-21

Study Completion Date

2025-11-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine if thigh muscle weakness and the lack of muscle activation that accompanies ACL injury can be improved through a form of mental coaching and encouragement, known as operant conditioning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thigh muscle weakness is a common result after anterior cruciate ligament (ACL) injury and reconstruction surgery. Therefore, reducing thigh muscle weakness after ACL injury and reconstructive surgery is important as the quadriceps muscles act as shock absorbers that protect the knee joint. If significant weakness is present in the quadriceps, the knee is exposed to increased forces and often results in degeneration of the structures in the joint leading to osteoarthritis. Thus, it is important to investigate activation and strength rehabilitation methods for the quadriceps muscles. This research study is being done to learn if thigh muscle weakness and the lack of muscle activation that accompanies ACL injury can be improved by conditioning brain responses (elicited by non-invasive transcranial magnetic stimulation) using a form of training called as operant conditioning.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Cruciate Ligament Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Operant Conditioning

Participants will receive operant conditioning training and single pulse transcranial magnetic stimulation 2-3 times a week for about 8 weeks.

Group Type EXPERIMENTAL

Operant Conditioning

Intervention Type BEHAVIORAL

Active encouragement and feedback to increase motor evoked response when stimulated.

Single Pulse Transcranial Magnetic Stimulation

Intervention Type DEVICE

Transcranial magnetic stimulation to elicit a motor evoked response from the quadriceps muscles.

Control

Participants will receive single pulse transcranial magnetic stimulation 2-3 times a week for about 8 weeks without operant conditioning training.

Group Type EXPERIMENTAL

Control

Intervention Type BEHAVIORAL

Absence of active encouragement and feedback to increase motor evoked response when stimulated.

Single Pulse Transcranial Magnetic Stimulation

Intervention Type DEVICE

Transcranial magnetic stimulation to elicit a motor evoked response from the quadriceps muscles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Operant Conditioning

Active encouragement and feedback to increase motor evoked response when stimulated.

Intervention Type BEHAVIORAL

Control

Absence of active encouragement and feedback to increase motor evoked response when stimulated.

Intervention Type BEHAVIORAL

Single Pulse Transcranial Magnetic Stimulation

Transcranial magnetic stimulation to elicit a motor evoked response from the quadriceps muscles.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 18-45 years
* suffered an acute, complete ACL rupture
* have undergone ACL reconstructive surgery
* willingness to participate in testing and follow-up as outlined in the protocol

Exclusion Criteria

* have suffered a previous ACL injury;
* have undergone previous major surgery to either knee;
* have a history of recent significant knee injury (other than ACL) or lower-extremity fracture;
* have a history of uncontrolled diabetes or hypertension;
* be pregnant or plan to become pregnant;
* have metal implants in the head;
* have electronic devices in their ear or heart (e.g., cochlear implants or cardiac pacemakers);
* have unexplained recurrent headaches;
* have a recent history of seizures;
* be taking drugs that reduce seizure threshold;
* have a history of repeated fainting spells;
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Michigan

OTHER

Sponsor Role lead

Medical University of South Carolina

OTHER

Sponsor Role collaborator

National Center of Neuromodulation for Rehabilitation

OTHER

Sponsor Role collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chandramouli Krishnan

Director of Neuromuscular and Rehabilitation Robotics Laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chandramouli Krishnan, PhD

Role: PRINCIPAL_INVESTIGATOR

Assistant Professor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P2CHD086844

Identifier Type: NIH

Identifier Source: secondary_id

View Link

HUM00130845

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.